Skip to Content

BlackRock Sus Adg Intl Eq Inv A BRZAX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 11.76  /  +0.26 %
  • Total Assets 16.7 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.18%
  • Turnover 118%

USD | NAV as of Jul 02, 2024 | 1-Day Return as of Jul 02, 2024, 10:10 PM GMT+0

Morningstar’s Analysis BRZAX

Will BRZAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin BlackRock Sus Adg Intl Eq Inv A's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRZAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.27 519,276
Healthcare

ASML Holding NV

2.85 452,305
Technology

AstraZeneca PLC

2.24 355,384
Healthcare

BlackRock Liquidity T-Fund Instl

2.18 345,282
Cash and Equivalents

Novartis AG Registered Shares

1.94 308,177
Healthcare

SAP SE

1.86 294,496
Technology

Shell PLC

1.85 293,855
Energy

Nestle SA

1.67 264,391
Consumer Defensive

Siemens AG

1.59 252,405
Industrials

Schneider Electric SE

1.48 235,056
Industrials